Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 10218
TargetSubstance-P receptor(Human)
Xwpharma

US Patent
LigandPNGBDBM520674(US11149006, Compound V)
Affinity DataIC50: 0.512nMAssay Description:Experimental procedure for competitive binding (Ki determination): Perform CisBio's Tag-Lite Tachykinin NK-1 binding assay according to manufactu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2022
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Xwpharma

US Patent
LigandPNGBDBM520672(US11149006, Compound IV | US11149006, Compound I)
Affinity DataIC50: 0.640nMAssay Description:Experimental procedure for competitive binding (Ki determination): Perform CisBio's Tag-Lite Tachykinin NK-1 binding assay according to manufactu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2022
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Xwpharma

US Patent
LigandPNGBDBM520672(US11149006, Compound IV | US11149006, Compound I)
Affinity DataIC50: 6.15nMAssay Description:Experimental procedure for NK-1, NK-2 and NK-3 calcium flux FLIPR assay: Perform the assay in the following steps: 1) Cell preparation: thaw each cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2022
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Xwpharma

US Patent
LigandPNGBDBM520672(US11149006, Compound IV | US11149006, Compound I)
Affinity DataIC50: 22.2nMAssay Description:Experimental procedure for NK-1, NK-2 and NK-3 calcium flux FLIPR assay: Perform the assay in the following steps: 1) Cell preparation: thaw each cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2022
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Xwpharma

US Patent
LigandPNGBDBM520672(US11149006, Compound IV | US11149006, Compound I)
Affinity DataIC50: 1.00E+4nMAssay Description:Experimental procedure for NK-1, NK-2 and NK-3 calcium flux FLIPR assay: Perform the assay in the following steps: 1) Cell preparation: thaw each cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2022
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Xwpharma

US Patent
LigandPNGBDBM520672(US11149006, Compound IV | US11149006, Compound I)
Affinity DataIC50: 1.00E+4nMAssay Description:Experimental procedure for NK-1, NK-2 and NK-3 calcium flux FLIPR assay: Perform the assay in the following steps: 1) Cell preparation: thaw each cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2022
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Xwpharma

US Patent
LigandPNGBDBM520672(US11149006, Compound IV | US11149006, Compound I)
Affinity DataIC50: 1.00E+4nMAssay Description:Experimental procedure for NK-1, NK-2 and NK-3 calcium flux FLIPR assay: Perform the assay in the following steps: 1) Cell preparation: thaw each cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2022
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Xwpharma

US Patent
LigandPNGBDBM520672(US11149006, Compound IV | US11149006, Compound I)
Affinity DataIC50: 1.00E+4nMAssay Description:Experimental procedure for NK-1, NK-2 and NK-3 calcium flux FLIPR assay: Perform the assay in the following steps: 1) Cell preparation: thaw each cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2022
Entry Details
Go to US Patent